Simvastatin Tablet, Film Coated
Product Images NDC 70518-3630

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 70518-3630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Footnote For Table 3 (Footnote For Table 3)

The text describes the results of a chemical assay that could potentially be indicative of several inhibitors of a certain enzyme, including ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone. The text also explains that simvastatin acid is the p-hydroxyacid of simvastatin. However, it is unclear whether grapefruit juice affects simvastatin pharmacokinetics as the effect of different amounts of grapefruit juice has not been studied. The text also provides information on the administration of grapefruit juice and simvastatin during an experiment.*

FDA Label Image

Remedy_label (Remedy Label)

Simvastatin is a medication available in tablet form with a strength of 20 mg. Each pack contains 30 tablets. The medication is only available with a valid prescription. The packaging includes the NDC number, RX only label, manufacturer details, and storage instructions. The package insert should be consulted before use. The medication should be stored at a temperature between 20-25°C (68-77°F) and should be kept away from children. The repackaging of the medication has been done by RemedyRepack Inc. located in Indiana, PA.*

FDA Label Image

Mm2 (Simvastatin 20mg 70518 3630 01)

This is a prescription drug called Simvastatin, which is available in a bottle of 90 tablets. The package insert contains information about how to use it. It is important to keep the medication out of the reach of children, and it should be stored at room temperature. The product is repackaged by RemedyRepack Inc. with a specific lot number and NDC number. The expiration date is not available.*

FDA Label Image

Figure 9 (Simvastatin 10)

FDA Label Image

Table2 (Simvastatin 2)

The table shows adverse reactions reported by patients treated with Simvastatin in comparison to those who took Placebo. It reports the percentage of patients who reported the reactions with a frequency of greater than or equal to 2%. The reactions are categorized by the body system that was affected, with some examples being: Edema/swelling, Atrial fibrillation, Diabetes mellitus, Bronchitis, Eczema, and Infection, urinary tract.*

FDA Label Image

Structure (Simvastatin 3)

FDA Label Image

Table 3 (Simvastatin 4)

FDA Label Image

Table 4 (Simvastatin 5)

FDA Label Image

Figure 5 (Simvastatin 6)

This appears to be a table with data on major vascular events and major coronary events in patients taking Simvastatin versus Placebo, categorized by different patient characteristics such as presence of cardiovascular diseases and other related conditions. However, without more context on the units of measurements and other important details, it is difficult to provide a more specific description.*

FDA Label Image

Figure 6 (Simvastatin 7)

FDA Label Image

Figure 7 (Simvastatin 8)

FDA Label Image

Figure 8 (Simvastatin 9)

FDA Label Image

Table 1 (Table1)

This appears to be a table showing drug interactions that increase the risk of myopathy/rhabdomyolysis. The table includes a list of drugs that can interact with Simvastatin, a medication used to lower cholesterol levels, leading to muscle damage. The list provides recommendations for prescribing medications, including which drugs to avoid or only take at lower doses when taking Simvastatin. It also lists drugs that can increase the risk of muscle damage, such as strong CYP3A4 inhibitors, HIV protease inhibitors, cyclosporine, and certain antibiotics. The last line appears to be garbled and therefore not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.